Orlistat

Orlistat (Orlistat) as a function of the central nervous system obesity drug treatment.
Only applies to the gastrointestinal tract, lipase by inhibiting the gastrointestinal tract, to prevent hydrolysis three acyl glycerin to free fatty acids and single acyl glyceride, reduce mucous membrane lumen to the absorption of dietary fat three acyl (glycerin), to promote fat out of in vitro.
Lipase enzyme for gastrointestinal necessary to break down fat, this product can be combined with the stomach, pancreatic lipase serine residues, enzyme inactivation, fat in the food can not be broken down into free fatty acid, inhibit fat utilization and absorption, in addition, this product can be reduce the risk factors associated with obesity.